HIV prevention pills delivered on wheels to High-Risk communities
NCT ID NCT04782180
Summary
This study tested whether providing HIV prevention medication (PrEP) immediately at a needle exchange program helps people stay HIV-negative. Researchers enrolled 90 adults who use the syringe service and tested negative for HIV. They measured if getting the medicine right at the exchange site improved how consistently people took it over six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Miami
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.